Bryan Martin Kahl, M.D.
NPI 1508905837ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Denison, TX
Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Denison, Texas, trained at University of Texas Medical School at San Antonio (class of 1993). Their prescriptions cost Medicare Part D more than their services did: $1,317,879 for 5,326 claims, against $218,616 paid for services in 2024. Novo Nordisk Inc was the largest of 22 companies reporting payments in 2025, $1,567 in all, mostly food and beverage.
Overview
| NPI | 1508905837 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Feb 5, 2007 |
| Last updated in NPPES | Jan 26, 2018 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | J6513 | TX |
| Internal Medicine | 207R00000X | J6513 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 706 |
|---|---|
| Services billed | 9,557 across 39 procedure codes |
| Paid by Medicare | $218,616 |
Part D prescriptions in 2024
| Prescriptions (claims) | 5,326 · 10,878 30-day fills |
|---|---|
| Patients | 630 |
| Total drug cost | $1,317,879 |
| Generic share | 49% of claims |
Education and affiliations
| Medical school | University of Texas Medical School at San Antonio |
|---|---|
| Graduation year | 1993 |
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- TexomacareDurant, OK · 47 clinicians
Hospital affiliation
- Texoma Medical CenterDenison, TX
Industry payments (Open Payments)
- 2025$1,567 · 91 payments from 22 companies
- 2024$2,476 · 85 payments from 20 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $238.53 | 17 |
| Amgen Inc. | $181.17 | 13 |
| Neurocrine Biosciences, Inc. | $173.43 | 7 |
| Xeris Pharmaceuticals, Inc. | $126.42 | 4 |
| Corcept Therapeutics | $108.61 | 6 |
What the 2025 payments were for
- Food and Beverage$1,543 · 90 payments
- Education$24.04 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Denison
- 1366763757
- 1558311605
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →